K

K


kalanchoe leaves herbal remedy for treatment of verruca (see Table C9)


Kaltostat highly absorbent calcium and sodium alginate wound dressing; forms a hydrophilic gel with wound exudate, maintaining a moist wound interface and preventing tissue maceration (see Table D10)


Kaposi’s sarcoma rare, virus-induced, tumour of vascular endothelium; affects elderly Jewish or middle-European men, and the immunosuppressed (it is especially aggressive in human immunodeficiency virus [HIV]-positive cases); presents in skin as multiple, well-circumscribed purple macules, e.g. of lower eyelids


KE20 white elastomer putty, mixed with a catalyst; used to form orthodigita or prosthetic toes


Kelikian push-up test see test, Kelikian push-up


Keller’s procedure first-ray arthroplasty to correct hallux rigidus; i.e. excision of proximal one-third of proximal phalanx of hallux, and first metatarsal head exostoses


keloid exuberant hypertrophic scarring, due to genetic trait, especially in African races


kelvin see scale, kelvin


keratin sulphur-containing, insoluble scleroprotein, forming stratum corneum, nail plate and hair shaft, from enzymic conversion of epidermal cells


keratinization enzymic conversion of epidermal skin cells to keratin


keratinocytes basal-layer epidermal cells, daughter cells of which move towards the exterior whilst undergoing gradual enzyme degradation to form keratin; their function includes forming cytoskeleton filaments and desmosomal connections, immune function, cutaneous inflammation and tissue repair (through cytokine secretion [e.g. interleukins, interferon, tumour necrosis factor-alpha] following tissue injury or in certain skin diseases)


keratoacanthoma rapid-growing, localized skin tumour; i.e. central mass of skin surface keratin which invades the dermis; undergoes spontaneous resolution


keratoderma blenorrhagicum psoriasis-like, yellowish, hyperkeratotic lesions of plantar skin; characteristic of late-stage Reiter’s disease


keratolysis separation or loosening of stratum corneum to form intraepidermal blisters (compare with acantholysis)


keratolytics topical agents that break down keratin (by breaking intermolecular bonds and causing maceration); assist removal of tough, outer stratum corneum, and penetration of keratolytic or caustic medicaments to deeper tissues, e.g. 10+% salicylic acid (see caustics; and Table C9, Table K1)


Table K1 Keratolytic and caustic agents




































































Keratolytic/caustic agent Indicated use
Whitfield’s ointment (3% salicylic acid and 6% benzoic acid in white soft paraffin) Treatment of mild tinea pedis
5% salicylic acid ointment Applied daily for 7 days to soften hyperkeratosis and facilitate its removal
12% salicylic acid in collodion Macerating agent; painted over callosity and left in situ for 7 days, to assist removal of heavy callosity
20–40% salicylic acid plaster Applied topically and left in situ for 1–2 days to aid removal of corns
40–70% salicylic acid ointment Applied topically in a cavitied pad and left in situ for 7 days for verruca treatment; the lesion should be masked
Calmurid cream (10% urea) To hydrate anhidrotic skin; applied daily to treat dyskeratosis
40% urea cream A strongly keratolytic agent, applied under an occlusive dressing and left in situ for 7 days, to soften, macerate and aid the reduction and removal of hypertrophied nails in patients who are unsuitable for nail avulsion
Monochloroacetic acid A deeply penetrating caustic that is painful in use Applied, retained in situ and reviewed within 3–7 days, for the treatment of verrucae:
1. as a saturated solution to the lesion
2. as a tiny crystal strapped over a masked lesion
3. as a tiny crystal embedded in 40–70% salicylic acid retained by a cavitied pad
Trichloroacetic acid A self-limiting caustic with a superficial action
Applied directly to the verruca, after initial scalpel debridement of the lesion
May be used in conjunction with 75–95% silver nitrate (see below) as a diagnostic or a final treatment of verrucae
75–95% Silver nitrate A self-limiting caustic with a superficial action, causing a dark brown discoloration of the skin to which it is applied; it is used for the treatment of shallow or mosaic verrucae.
Note: Some patients show an idiosyncratic local sensitivity or inflammatory reaction to applied silver nitrate
1. Applied directly to the lesion, after overlying callosity has been debrided off
2. Applied directly to the lesion in alternating layers with trichloroacetic acid
3. As a diagnostic aid to identify verrucous tissue; viral-infected skin cells show up as bright white dots within a few moments of the application of the layers of silver nitrate and trichloroacetic acid
Potassium hydroxide (KOH) A powerful keratolytic caustic with a great affinity for water that penetrates deeply dissolving precipitated protein; used to destroy soft tissues
1. Overlying hyperkeratosis is debrided off the verruca and the foot is immersed in water for 5 minutes to hydrate the skin, then dried; a KOH pellet is rubbed into the lesion; the foot is reimmersed in water and the jelly-like material formed by the KOH on the lesion surface is debrided off. The process is repeated once or twice until the lesion appears to have gone, then glacial acetic acid is applied to neutralize the KOH
2. A similar protocol may be used to ablate nail matrix after removal of the overlying section of nail plate
3. KOH 5% liquid applied to heavy callosity and left in situ for 5 minutes softens heavy callosity to ease its removal
Pyrogallol (pyrogallic acid) A powerful analgesic, non-self-limiting, caustic reducing agent. It may be used in the treatment of recalcitrant verrucae or neurovascular corns in areas of skin overlying a healthy layer of fibrofatty padding. It should only be used with great caution as its action continues after application has ceased and can lead to severe tissue breakdown that is slow to heal. It is incompatible with alkalis, iron salts, oxidizing agents and ammonium salts
1. 20% pyrogallol ointment for the treatment of neurovascular corns
2. 40% pyrogallol ointment for the treatment of VP
3. WP ointment (20% pyrogallol, 20% wheat germ oil) for the treatment of tough, fibrous, hyperkeratotic plantar lesions
Phenol An analgesic, corrosive caustic. It is used as an 80% solution (liquefied phenol) to destroy soft-tissue lesions such as VP, or nail matrices (three applications, each of 1 minute duration). Its action is quenched by dilution with IMS or isopropyl alcohol. Healing is delayed for several weeks after its application
Glacial acetic acid A weakly acidic mild caustic that is crystalline at 14°C
1. As a paint to hard or vascular corns, or VP (return period 14–21 days)
2. As a paint to VP, alternating with silver nitrate 75% (in a similar manner to trichloroacetic acid)
3. To neutralize KOH (see above: KOH, point 1)
Nitric acid A powerful analgesic oxidizing caustic agent with a superficial action that offers a ‘one-off’ VP treatment
1. Applied to VP with a glass rod and left in situ for 5 minutes, followed by phenol solution 10%; the skin stains bright yellow
2. The lesion is saturated with phenol solution 5% for 5 minutes, then with nitric acid for 20–30 seconds, then once again with phenol solution 5%
Strong iodine solution (iodine solution 10%; iodine fortis) A strong astringent and vesicant agent. It is incompatible with many topical medicaments, and can cause sensitivity reactions in some patients
1. to shrink nail tufts
2. to shrink hypergranulation tissue
Formaldehyde A strongly astringent and antiseptic agent used in the treatment of VPs (the skin surrounding the lesion should be protected with petroleum jelly; sensitivity is likely)
1. 10% formaldehyde in collodion, painted on daily
2. 36% formaldehyde solution, painted on daily
Thermal caustics
Cryosurgery The topical application of liquid nitrogen (at −196°C) or nitrous oxide (at −88.5°C) to destroy small soft-tissue lesions; the cell cytoplasm must be reduced to and maintained at −24°C or lower for at least 1 minute, and repeated for two further freezing episodes between which the area has been allowed to thaw. Cryosurgery is more effective when any overlying hyperkeratosis is removed before freezing
Hyfrecation Tissue destruction by initial fulguration (outlining and superficial charring) of the lesion by the application of high-frequency electrical energy), then electrodesiccation (electrocautery) of the lesion by the release of electrical energy whilst the probe is inserted into the lesion
Electrosurgery Tissue removal using high-frequency energy waves to incise through tissue

Note: Please also refer to the text entries for each listed agent.


IMS, industrial methylated spirit; VP, verrucae pedis.


keratoma; tyloma callosity


keratopachyderma autosomal-dominant syndrome characterized by congenital deafness, palmar and plantar (and elbows and knees) hyperkeratosis and band-like digital constrictions


keratoplastic topical agent softening keratin; e.g. 6% salicylic acid


keratosis any epidermal lesion characterized by discrete stratum corneum overgrowth


keratosis follicularis see disease, Darier’s


ketamine hydrochloride N-methyl-d-aspartate (NMDA)-receptor antagonist used to reduce intraoperative pain; contraindicated in hypertensive patients


ketoacidosis acidosis due to overproduction of ketone (acetone) bodies; characteristic of uncontrolled diabetes mellitus; fatal if left untreated (see acetonuria; diabetic coma; ketoacidotic coma)


ketoacidotic coma loss of consciousness due to generalized ketosis in uncontrolled diabetes mellitus; needs emergency treatment with systemic insulin and hospitalization; see ketotic patients


ketoconazole; Nizoral imidazole antifungal agent, not effective against toenail onychomycosis; patients on systemic ketoconazole should be monitored for liver function; systemic dose = 200 mg daily for 14 days


ketone bodies body fat breakdown products; an alternative energy source to glucose, e.g. in uncontrolled diabetes mellitus and starvation; excreted in urine and breath, causing smell of acetone (pear drops)


ketoprofen; ketorolac non-steroidal anti-inflammatory drugs used to control pain and mild inflammation, e.g. after bone surgery, in acute gout, rheumatic disease and other musculoskeletal disorders


ketosis enhanced ketone production; see ketoacidosis


ketotic patients early stage of diabetic ketoacidosis, characterized by acetone-tainted breath and urine, facial flushing, increasing drowsiness and confusion, dehydration, Kussmaul respiration and, ultimately, coma (see acidosis)


Kidner procedure surgical technique – navicular resection and reroute of posterior tibial tendon; used to correct chronic posterior tibial muscle dysfunction in cases presenting with a hypertrophied or accessory navicular


kidney disease in diabetes mellitus; end-stage kidney (renal) failure initial microalbuminuria, progressing (in 80% of cases) to persistent proteinuria (i.e. >500 mg protein in urine in 24 hours, on three occasions in a 6-month period), increasing hypertension and progressive cardiovascular disease; affects type 1 and type 2 diabetics


kinase enzyme catalysing conversion of a proenzyme to an active enzyme; e.g. adenosine triphosphate (ATP) protein kinase (catalyses formation of ATP from adenosine diphosphate)


kinesis movement


kinetic analysis gait analysis describing causes of motion within body segments, in terms of their displacement, velocity and acceleration


kinins substances that cause vascular smooth-muscle relaxation, inducing vasodilatation and inflammation


Kistler force plate method of computerized gait analysis Table G2


knee ginglyomoarthroidal joint between inferior femur and superior tibia; permits sagittal-plane flexion and extension of tibia on femur, and transverse rotation of femur on (static) weight-bearing tibia; at any one time only a small area of each convex femoral condyle articulates with the central area of each slightly concave tibial condyle; the space at the periphery of these articulations is infilled by a C-shaped rim of fibrocartilage (menisci) which deepen the articular cup for the distal femur; assists leg shock absorption and deceleration mechanisms (maximum foot pronation coincides with knee flexion during the gait cycle)


Stay updated, free articles. Join our Telegram channel

Jun 12, 2017 | Posted by in ANATOMY | Comments Off on K

Full access? Get Clinical Tree

Get Clinical Tree app for offline access